Gigamon Inc. (NYSE:GIMO)
Gigamon Inc. is engaged in providing intelligent Traffic Visibility solutions for enterprises, data centers and service providers. Its products consist of GigaVUE, GigaSECURE, GigaSMART and GigaTAP products. The Company’s fabric enables information technology organizations to forward traffic from network infrastructure to management, analysis, and compliance and security tools. It has operations primarily in the United States, the rest of North America, Europe, the Middle East, Africa, and the Asia Pacific. Gigamon Inc. is headquartered in Milpitas, California.
Gigamon Inc. (NYSE:GIMO)’s Financial Overview
Gigamon Inc. (NYSE:GIMO) declined -9.88% yesterday to close its trading session at $53.35. The company has 1 year Price Target of $60.17. Gigamon Inc. has 52-Week high of $61.25 and 52-Week Low of $21.23. The stock touched its 52-Week High on Nov 25, 2016 and 52-Week Low on Feb 8, 2016. The stock traded with the volume of 1.9 Million shares yesterday. The firm shows the market capitalization of $1.93 Billion.
Gigamon Inc. (NYSE:GIMO) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.36/share against the analyst consensus estimate of $0.31/share. The difference between the actual and expected EPS is $0.05 a share with a surprise factor of 16.1%.
The firm is trading with SMA20 of -7.13 Percent, SMA50 of -1.79 Percent and SMA200 of 32.4 percent. Gigamon Inc. has P/S value of 6.58 while its P/B value stands at 7.8. Similarly, the company has Return on Assets of 14.5 percent, Return on Equity of 23.1 percent and Return on Investment of 3.8 Percent. The company shows Gross Margin and Operating Margin of 81.9 percent and 9.3 percent respectively.
Many brokerage firms are involved in issuing their ratings on Gigamon Inc. (NYSE:GIMO). On 13-Oct-16 BofA/Merrill Upgrade Gigamon Inc. Stock to Buy. Another firm also rated the stock on 5-Oct-16 where DA Davidson Downgrade the stock to Neutral.
The Stock currently has Analyst’ mean Recommendation of 2.2 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 6 analysts offering 12-month price forecasts for Gigamon Inc have a median target of 59.00, with a high estimate of 70.00 and a low estimate of 53.00. The median estimate represents a +10.59% increase from the last price of 53.35.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
UnitedHealth Group Incorporated (NYSE:UNH)
UnitedHealth Group Inc. offers health care coverage and related services to help people achieve improved health and well-being through all stages of life. The company’s products and services reflect a number of core capabilities, including medical information management, health benefit administration, care coordination, risk assessment and pricing, health benefit design and provider contracting. With these capabilities, it is able to provide comprehensive health care management services through organized health systems and insurance products.
UnitedHealth Group Incorporated (NYSE:UNH)’s Financial Outlook
The 22 analysts offering 12-month price forecasts for UnitedHealth have a median target of 165.50, with a high estimate of 185.00 and a low estimate of 116.00. The median estimate represents a +4.54% increase from the last price of 158.32.
UnitedHealth Group Incorporated is estimated to report earnings on 01/17/2017. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 10 analysts’ forecasts, the consensus EPS forecast for the quarter is $2.07. The reported EPS for the same quarter last year was $1.4.
According to Zacks Investment Research, UnitedHealth Group Incorporated has a Consensus Recommendation of 1.47. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock gained 0.46% and closed its last trading session at $158.32. The company has the market capitalization of $150.69 Billion. The stock has 52-week high of $159.76 and 52-Week low of $107.51. The firm touched its 52-Week high on Nov 30, 2016 and 52-Week low on Jan 14, 2016. The company has volume of 7.14 Million shares. The company has a total of 951.82 Million shares outstanding.
UnitedHealth Group Incorporated (NYSE:UNH) in the last quarter reported its actual EPS of $2.17/share where the analyst estimated EPS was $2.08/share. The difference between the actual and Estimated EPS is $0.09. This shows a surprise factor of 4.3 percent.
The company has YTD performance of 36.38 percent. Beta for UnitedHealth Group Incorporated stands at 0.66 while its ATR (average true range) is 2.89. The company has Weekly Volatility of 1.72%% and Monthly Volatility of 1.97%%.
UnitedHealth Group Incorporated has distance from 20-day Simple Moving Average (SMA20) of 7.4%, Distance from 50-Day Simple Moving Average of 10.92 percent and Distance from 200-Day Simple Moving Average of 16.99%.
The Company currently has ROA (Return on Assets) of 5.5 percent, Return on Equity (ROE) of 18.3 Percent and Return on Investment (ROI) of 10.1% with Gross margin of 0 percent and Operating & Profit margin of 6.7% and 3.6% respectively.